These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33096337)

  • 1. Classification of gastric cancers based on immunogenomic profiling.
    Liu Z; Jiang Z; Wu N; Zhou G; Wang X
    Transl Oncol; 2021 Jan; 14(1):100888. PubMed ID: 33096337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of triple-negative breast cancers based on Immunogenomic profiling.
    He Y; Jiang Z; Chen C; Wang X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):327. PubMed ID: 30594216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel immune subtypes identification of HER2-positive breast cancer based on immunogenomic landscape.
    Huang L; Liu X; Li L; Wang L; Wu N; Liu Z
    Med Oncol; 2022 May; 39(5):92. PubMed ID: 35568771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenomic Profiling and Classification of Prostate Cancer Based on HIF-1 Signaling Pathway.
    Song J; Chen W; Zhu G; Wang W; Sun F; Zhu J
    Front Oncol; 2020; 10():1374. PubMed ID: 32850440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma.
    Liu Q; Nie R; Li M; Li L; Zhou H; Lu H; Wang X
    Comput Struct Biotechnol J; 2021; 19():4472-4485. PubMed ID: 34471493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of Osteosarcoma Based on Immunogenomic Profiling.
    Wang X; Wang L; Xu W; Wang X; Ke D; Lin J; Lin W; Bai X
    Front Cell Dev Biol; 2021; 9():696878. PubMed ID: 34336848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling.
    Lu Q; Nie R; Luo J; Wang X; You L
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment characterization in stage IV gastric cancer.
    Zhang X; Yang F; Wang Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33416081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of molecular features correlating with tumor immunity in gastric cancer by multi-omics data analysis.
    He Y; Wang X
    Ann Transl Med; 2020 Sep; 8(17):1050. PubMed ID: 33145269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling.
    Wei Y; Ou T; Lu Y; Wu G; Long Y; Pan X; Yao D
    PeerJ; 2020; 8():e10414. PubMed ID: 33282564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profiling.
    Xiang R; Song W; Ren J; Wu J; Fu J; Fu T
    Stem Cell Res Ther; 2021 Oct; 12(1):563. PubMed ID: 34717747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy.
    Xu F; Chen JX; Yang XB; Hong XB; Li ZX; Lin L; Chen YS
    Mol Ther Oncolytics; 2020 Jun; 17():241-249. PubMed ID: 32346613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling.
    Zhou X; Qiu S; Nie L; Jin D; Jin K; Zheng X; Yang L; Wei Q
    Front Oncol; 2020; 10():1429. PubMed ID: 32974156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of gastric cancer subtypes based on pathway clustering.
    Li L; Wang X
    NPJ Precis Oncol; 2021 Jun; 5(1):46. PubMed ID: 34079012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unsupervised Hierarchical Clustering Identifies Immune Gene Subtypes in Gastric Cancer.
    Cao J; Gong J; Li X; Hu Z; Xu Y; Shi H; Li D; Liu G; Jie Y; Hu B; Chong Y
    Front Pharmacol; 2021; 12():692454. PubMed ID: 34248641
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.
    Companioni O; Sanz-Anquela JM; Pardo ML; Puigdecanet E; Nonell L; García N; Parra Blanco V; López C; Andreu V; Cuatrecasas M; Garmendia M; Gisbert JP; Gonzalez CA; Sala N
    PLoS One; 2017; 12(4):e0176043. PubMed ID: 28441455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer.
    Jiang Z; Liu Z; Li M; Chen C; Wang X
    Transl Oncol; 2018 Oct; 11(5):1171-1187. PubMed ID: 30059832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined immune and DDR pathway classifier: A novel pathway-based classification aimed at tailoring personalized therapies for acute myeloid leukemia patients.
    Huang Y; Zhang Y; Zhou Q; Teng Y; Sui M; Zhang F
    Comput Biol Med; 2023 Aug; 162():107093. PubMed ID: 37269679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients.
    Kim Y; Cho MY; Kim J; Kim SN; Oh SC; Lee KA
    Oncotarget; 2017 Sep; 8(41):69888-69905. PubMed ID: 29050249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
    Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
    Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.